Fractyl Health

Fractyl Health is a metabolic therapeutics company focused on the treatment of metabolic diseases, including T2D and obesity.

Injectable obesity weight loss
MedTech

Endoscopic procedure can help slow weight rebound from GLP-1s

A simple outpatient procedure can help those on Eli Lilly’s obesity drug tirzepatide keep most of their weight off when stopping the med.
Ben Adams Apr 27, 2026 8:48am
Inside the small intestine

Fractyl delivers data on its device for GLP-1 weight maintenance

Sep 30, 2025 12:10pm
Inside the small intestine

Fractyl pivots T2D therapy to obesity & GLP-1s, lays off staff

Jan 31, 2025 11:45am
Long haired red satin mouse on scales

Fractyl's GLP-1 gene therapy makes weight loss last in mice

Jun 24, 2024 11:11am
Wall Street IPO initial public offering markets shares stock

Alto, Fractyl head to public markets with IPOs north of $100M

Feb 2, 2024 8:14am
Photo of Wall Street street sign with american flags in the background

Alto aims for $101M IPO to pave neuro development climb

Jan 30, 2024 11:37am